CytoReason is a biotechnology company that specializes in using advanced computational models to understand and predict disease mechanisms and drug responses. The company leverages its proprietary platform, which integrates vast amounts of biological data, to create detailed simulations of human immune systems. This technology aims to enhance drug development processes, improve patient stratification, and facilitate personalized medicine approaches. CytoReason collaborates with pharmaceutical companies and research institutions to optimize therapeutic strategies and accelerate the discovery of new treatments.